AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
185.67
+0.34 (0.18%)
At close: May 29, 2026, 4:00 PM EDT
186.00
+0.33 (0.18%)
After-hours: May 29, 2026, 7:54 PM EDT
AstraZeneca Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 60,439 | 58,739 | 54,073 | 45,811 | 44,351 | 37,417 | |
Revenue Growth (YoY) | 9.93% | 8.63% | 18.04% | 3.29% | 18.53% | 40.58% |
Cost of Revenue | 11,070 | 10,633 | 10,207 | 8,268 | 12,391 | 12,437 |
Gross Profit | 49,369 | 48,106 | 43,866 | 37,543 | 31,960 | 24,980 |
Selling, General & Admin | 20,946 | 20,512 | 20,532 | 19,755 | 18,955 | 15,680 |
Research & Development | 14,565 | 14,232 | 13,583 | 10,935 | 9,762 | 9,736 |
Other Operating Expenses | -457 | -381 | -252 | -1,340 | -514 | -1,492 |
Total Operating Expenses | 35,054 | 34,363 | 33,863 | 29,350 | 28,203 | 23,924 |
Operating Income | 14,315 | 13,743 | 10,003 | 8,193 | 3,757 | 1,056 |
Interest Income | 349 | 353 | 430 | 332 | 90 | -21 |
Interest Expense | -1,750 | -1,694 | -1,742 | -1,626 | -1,346 | -1,300 |
Total Non-Operating Income (Expense) | -1,401 | -1,341 | -1,312 | -1,294 | -1,256 | -1,321 |
Pretax Income | 12,914 | 12,402 | 8,691 | 6,899 | 2,501 | -265 |
Provision for Income Taxes | 2,521 | 2,169 | 1,650 | 938 | -792 | -380 |
Net Income | 10,389 | 10,225 | 7,035 | 5,955 | 3,288 | 112 |
Minority Interest in Earnings | 4 | 8 | 6 | 6 | 5 | 3 |
Net Income to Common | 10,389 | 10,225 | 7,035 | 5,955 | 3,288 | 112 |
Net Income Growth | 33.67% | 45.34% | 18.14% | 81.11% | 2835.71% | -96.50% |
Shares Outstanding (Basic) | 3,101 | 3,100 | 3,100 | 3,098 | 3,096 | 2,836 |
Shares Outstanding (Diluted) | 3,122 | 3,124 | 3,126 | 3,124 | 3,120 | 2,854 |
Shares Change (YoY) | -0.02% | -0.06% | 0.06% | 0.13% | 9.32% | 8.68% |
EPS (Basic) | 3.35 | 3.30 | 2.27 | 1.92 | 1.06 | 0.04 |
EPS (Diluted) | 3.33 | 3.27 | 2.25 | 1.91 | 1.05 | 0.04 |
EPS Growth | 33.53% | 45.33% | 18.11% | 80.57% | 2537.50% | -96.72% |
Shares Outstanding | 3,102 | 3,102 | 3,101 | 3,100 | 3,100 | 3,099 |
Free Cash Flow | 11,293 | 11,765 | 9,937 | 8,984 | 8,717 | 4,872 |
Free Cash Flow Growth | -4.01% | 18.40% | 10.61% | 3.06% | 78.92% | 26.94% |
Free Cash Flow Per Share | 3.62 | 3.77 | 3.18 | 2.88 | 2.79 | 1.71 |
Dividends Per Share | 3.200 | 3.200 | 3.100 | 2.900 | 2.900 | 2.870 |
Dividend Growth | - | 3.23% | 6.90% | - | 1.04% | 2.50% |
Gross Margin | 81.68% | 81.90% | 81.12% | 81.95% | 72.06% | 66.76% |
Operating Margin | 23.69% | 23.40% | 18.50% | 17.88% | 8.47% | 2.82% |
Profit Margin | 17.20% | 17.42% | 13.02% | 13.01% | 7.42% | 0.31% |
FCF Margin | 18.68% | 20.03% | 18.38% | 19.61% | 19.65% | 13.02% |
EBITDA | 20,130 | 19,476 | 16,691 | 13,580 | 9,237 | 7,586 |
EBITDA Margin | 33.31% | 33.16% | 30.87% | 29.64% | 20.83% | 20.27% |
EBIT | 14,315 | 13,743 | 10,003 | 8,193 | 3,757 | 1,056 |
EBIT Margin | 23.69% | 23.40% | 18.50% | 17.88% | 8.47% | 2.82% |
Effective Tax Rate | 19.52% | 17.49% | 18.99% | 13.60% | -31.67% | 143.40% |